Latest News for: janus janus

Edit

Dibadj: Uncertainty is pushing people to act globally, not just locally

CNBC 15 Apr 2025
Ali Dibadj, CEO of Janus Henderson Investors, says global investors are shifting away from U.S. assets amid uncertainty, favoring active investing, high-quality names, and emerging markets opportunities ... .
Edit

Recognising Palestine would be a huge mistake for Labour

AOL 15 Apr 2025
There is a distasteful irony in the attitude that those on the progressive Left have towards Britain ... Palestine is a good example of this Janus-like approach to diplomacy ... But this misunderstands Arab opinion in the Middle East ... .
Edit

Rheumatoid Arthritis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Revenue, Statistics, Therapies, ...

GetNews 15 Apr 2025
OLUMIANT is an immunosuppressant that is indicated for use in inflammatory and autoimmune diseases, or in other terms, it is defined as a Janus kinase (JAK) inhibitor used to treat adults with ...
Edit

US tariff hammer to miss the nail

Dawn 14 Apr 2025
Pressure is mounting on Trump as recession risk rises. “The recession risk is much, much higher now than it was a couple weeks ago,” noted Adam Hetts, global head of multi-asset at Janus Henderson ... “There will be shifting, I think, in supply chains... .
Edit

YOUR SUNDAY READING LIST: A Massive March, a Police Accountability Hero, and Not-So Hygienic Recycling

Portland Mercury 13 Apr 2025
by Wm. Steven Humphrey ... Suzette Smith. • POP QUIZ PDX!. In this week's local trivia game ... If you liked Stranger by the Lake (2013), director Alain Guiraduie has another queer smoldering mystery for you—Misericordia! Sideshow and Janus Films.
Edit

Trump defends tariff policy after China strikes back

Dawn 12 Apr 2025
Hits US with 125pc tariff hike; tells Washington to stop ‘destructive behaviour’ ... BEIJING ... “Recession risk is much, much higher now than it was a couple weeks ago,” noted Adam Hetts, global head of multi-asset at Janus Henderson ... .
Edit

Revolutionary Centrifuge V3 Platform Unleashes Real-World Asset Tokenization with Wormhole

Bitcoin World 11 Apr 2025
Treasury fund, managed by established players like Anemoy and Janus Henderson, speaks volumes about the platform’s maturity and appeal to institutional investors.
Edit

China hits back at Donald Trump’s tariff hike with 125% duty

Business Day 11 Apr 2025
Gold, a safe haven for investors in times of crisis, scaled a record high. “Recession risk is much, much higher now than it was a couple weeks ago,” said Adam Hetts, global head of multi-asset at Janus Henderson ... China deal? ... Reuters .
Edit

China Hikes Tariffs for US Imports in Response to Trump’s Actions

MarineLink 11 Apr 2025
Beijing increased its tariffs on U.S. imports to 125% on Friday, hitting back against U.S ... "Recession risk is much, much higher now than it was a couple weeks ago," said Adam Hetts, global head of multi-asset at Janus Henderson ... and China ... U.S.
Edit

China�Hits�Back at Trump Tariff Hike, US Stands Its Ground

gCaptain 11 Apr 2025
BEIJING/WASHINGTON/LONDON, April 11 (Reuters)�–�Beijing�increased its tariffs�on U.S ... U.S ... “Recession risk is much, much higher now than it was a couple weeks ago,” said Adam Hetts, global head of multi-asset at Janus Henderson ... U.S.
Edit

China hits back at Trump tariff hike, US stands its ground

Hindustan Times 11 Apr 2025
*. China hits back at Trump tariff hike, US stands its ground ... * ... * ... *. U.S. says 75 countries want trade talks. * ... * ... "Recession risk is much, much higher now than it was a couple weeks ago," said Adam Hetts, global head of multi-asset at Janus Henderson.
Edit

Ulcerative Colitis Market Set for Robust Growth Across the 7MM from USD 8.4 Billion in ...

GetNews 11 Apr 2025
The ulcerative colitis treatment market currently encompasses multiple therapeutic approaches, including aminosalicylates, corticosteroids, immunomodulators, biologic therapies, S1P modulators, and Janus kinase inhibitors ... Visit the ... Table of Contents.
Edit

Alopecia Areata Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 11 Apr 2025
It covers the Alopecia Areata pipeline drugs profiles, including clinical and nonclinical stage products ... Concert Pharmaceuticals. Concert Pharmaceuticals is developing deuruxolitinib (CTP-543), an oral inhibitor of Janus kinases JAK1 and JAK2 ... EQ101.
Edit

Chronic Hand Eczema Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | ...

GetNews 11 Apr 2025
The study evaluated Anzupgo® (delgocitinib) 20mg/g cream, a topical pan-Janus kinase (JAK) inhibitor, for the potential treatment of moderate to severe Chronic Hand Eczema (CHE) in Chinese ...
×